IL28B genotype does not correlate with HIV control in African Americans
- PMID: 21884517
- PMCID: PMC3170134
- DOI: 10.1111/j.1752-8062.2011.00307.x
IL28B genotype does not correlate with HIV control in African Americans
Erratum in
- Clin Transl Sci. 2013 Aug;6(4):331
Abstract
Background: HIV-1 natural viral suppressors (NVS) are individuals that control HIV replication without antiretrovirals (also know as HIV elite controllers). We have recently shown that these individuals have an elevated rate of hepatitis C virus (HCV) clearance. Given the association of IL28B genotype, specifically the rs12979860 single nucleotide polymorphism (SNP) based CC genotype, with HCV clearance, we studied its association with HIV control in 172 African American HIV subjects and 173 race-matched controls.
Findings: The frequency of the CC genotype was 12.5% in the NVS, 14.7% in the LVL ("low viral load" cohort with 400-20,000 HIV-1 RNA copies/mL), 17.8% in the MHVL ("medium/high viral load" cohort with >20,000 HIV-1 RNA copies/mL), and 11.6% in an HIV-negative cohort. There was no statistical significance in the CC genotype distribution between these cohorts (p= 0.48 between the NVS and non-NVS HIV positive controls, p= 0.85 between NVS and HIV-negatives). We also did not observe any association between CC genotype distribution and HIV RNA viral load, as a continuous measure.
Conclusions: The IL28B CC genotype does not account for the noted HIV control in our specific NVS cohort. Further studies will be needed to determine if a common genetic factor can primarily account for any joint clearance of HCV and control of HIV.
© 2011 Wiley Periodicals, Inc.
Similar articles
-
IL28B gene polymorphisms and viral kinetics in HIV/hepatitis C virus-coinfected patients treated with pegylated interferon and ribavirin.AIDS. 2011 May 15;25(8):1025-33. doi: 10.1097/QAD.0b013e3283471cae. AIDS. 2011. PMID: 21505315 Free PMC article.
-
Protective interleukin-28B genotype affects hepatitis C virus clearance, but does not contribute to HIV-1 control in a cohort of African-American elite controllers/suppressors.AIDS. 2011 Jan 28;25(3):385-7. doi: 10.1097/QAD.0b013e328341b86a. AIDS. 2011. PMID: 21099664 Free PMC article.
-
Association between IL28B gene polymorphisms and plasma HCV-RNA levels in HIV/HCV-co-infected patients.AIDS. 2011 Mar 27;25(6):761-6. doi: 10.1097/QAD.0b013e32834488e7. AIDS. 2011. PMID: 21378537
-
IL28B single-nucleotide polymorphism rs12979860 is associated with spontaneous HIV control in white subjects.J Infect Dis. 2013 Feb 15;207(4):651-5. doi: 10.1093/infdis/jis717. Epub 2012 Dec 7. J Infect Dis. 2013. PMID: 23225905
-
IL28B polymorphism (rs12979860) associated with clearance of HCV infection in Poland: systematic review of its prevalence in chronic hepatitis C patients and general population frequency.Pharmacol Rep. 2015 Apr;67(2):260-6. doi: 10.1016/j.pharep.2014.10.006. Epub 2014 Oct 23. Pharmacol Rep. 2015. PMID: 25712648
Cited by
-
Human leukocyte antigen B*57 does not fully explain hepatitis C clearance in HIV controllers.AIDS. 2013 Nov 13;27(17):2691-6. doi: 10.1097/01.aids.0000433242.86362.21. AIDS. 2013. PMID: 23939233 Free PMC article.
-
Interleukin gene polymorphisms and susceptibility to HIV-1 infection: a meta-analysis.J Genet. 2018 Mar;97(1):235-251. J Genet. 2018. PMID: 29666343
-
Gene-disease association with human IFNL locus polymorphisms extends beyond hepatitis C virus infections.Genes Immun. 2016 Jul;17(5):265-75. doi: 10.1038/gene.2016.24. Epub 2016 Jun 9. Genes Immun. 2016. PMID: 27278127 Free PMC article. Review.
-
A Role of Variance in Interferon Genes to Disease Severity in COVID-19 Patients.Front Genet. 2021 Sep 17;12:709388. doi: 10.3389/fgene.2021.709388. eCollection 2021. Front Genet. 2021. PMID: 34603376 Free PMC article. Review.
-
HIV Diagnosis and Treatment through Advanced Technologies.Front Public Health. 2017 Mar 7;5:32. doi: 10.3389/fpubh.2017.00032. eCollection 2017. Front Public Health. 2017. PMID: 28326304 Free PMC article. Review.
References
-
- Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, et al Genetic variation in IL28B predicts hepatitis C treatment‐induced viral clearance. Nature. 2009; 461(7262): 399–401. Epub 2009 Aug 16. - PubMed
-
- Rallón NI, Naggie S, Benito JM, Medrano J, Restrepo C, Goldstein D, Shianna KV, Vispo E, Thompson A, McHutchison J, et al Association of a single nucleotide polymorphism near the interleukin‐28B gene with response to hepatitis C therapy in HIV/hepatitis C virus‐coinfected patients. AIDS. 2010; 24(8): F23–F29. - PMC - PubMed
-
- Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, Kuestner R, Garrigues U, Birks C, Roraback J, et al IL‐28, IL‐29 and their class II cytokine receptor IL‐28R. Nat Immunol. 2003; 4(1): 63–68. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical